COMMUNIQUÉS West-GlobeNewswire

Nevakar Completes $30 Million Financing to Advance Pipeline Products
29/11/2018
BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Nevakar Inc., a specialty pharmaceutical company developing multiple differentiated products in the ophthalmic and injectable areas, announced today that it has [...]
PotNetwork Holdings, Inc.’s Diamond CBD Launches Program To Sell Its Products in Shopping Malls Across America on Black Friday at Broward Mall in South Florida
29/11/2018
New Program Focusing on Educating Consumers on the Benefits of Diamond CBD to Build Brand Preference FORT LAUDERDALE, Fla., Nov. 29, 2018 (GLOBE NEWSWIRE) -- PotNetwork Holdings, Inc. (OTC Pink: POTN ) announced today [...]
AMAG Pharmaceuticals Awards Four Grants to Further Research in Preterm Birth and Preeclampsia
29/11/2018
WALTHAM, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- As part of the company’s annual grant program to support research to reduce preterm birth and preeclampsia and associated complications, AMAG Pharmaceuticals, Inc. ( [...]
Daré Bioscience, Inc. Announces Initiation of Content Validity Study for Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
29/11/2018
Sildenafil Cream, 3.6% has the Potential to Receive the First FDA Approval for Female Sexual Arousal Disorder SAN DIEGO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc . (NASDAQ: DARE), a leader in clinical- [...]
InspireMD Announces Positive Long-Term Safety and Efficacy Data from Ongoing CGuard™ EPS Registries at the Recent 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium)
29/11/2018
TEL AVIV, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery [...]
T1D Exchange Teams with Tidepool to Leverage Device Data for Groundbreaking Study of Type 1 Diabetes
29/11/2018
Researchers to Focus on Daily, Mild to Moderate Fluctuations in Glucose Levels and the Impact on Patient Wellness BOSTON, Nov. 29, 2018 (GLOBE NEWSWIRE) -- T1D Exchange today announced a research partnership with [...]
International Prix Galien Recognizes SPINRAZA® as Best Biotechnology Product
29/11/2018
Rare disease therapy honored with seven Prix Galien awards, including six independent country recognitions, for innovation in treating spinal muscular atrophy CAMBRIDGE, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Biogen [...]
MacroGenics and Zai Lab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Margetuximab, MGD013 and TRIDENT™ Molecule in Greater China
29/11/2018
Comprehensive collaboration across three MacroGenics’ pipeline programs to accelerate and expand ongoing development Expand Zai Lab’s late-stage clinical pipeline with margetuximab and obtain rights to first-in-class [...]
The Real Impact of PAD - Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease
29/11/2018
HAIFA, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that [...]
Loop Industries Establishes Multi-Year Supply Framework with the Coca-Cola Cross Enterprise Procurement Group
29/11/2018
New Agreement Enables Authorized Coca-Cola Bottlers to Enter into Supply Agreements to Secure 100% Sustainable Loop™ Branded PET Plastic Resin MONTREAL, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq: [...]
Transactions under Novozymes’ stock buyback program
29/11/2018
Novozymes has now completed the announced share buyback program of B shares worth up to DKK 2 billion in total during 2018. Please read the full announcement in the attached PDF Attachment 2018_66_Stock_Buybackprogram_EN
Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories
29/11/2018
BUFFALO, N.Y., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Voyager Therapeutics Enters into Strategic Manufacturing Collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies
29/11/2018
Collaborations to provide Voyager the ability and flexibility to transfer its manufacturing expertise across multiple high-quality vendors to support the development of its pipeline programs CAMBRIDGE, Mass., Nov. 29, [...]
Akcea Announces Upcoming Data Presentations at the 2018 American Society of Hematology Annual Meeting
29/11/2018
Presentations focus on the benefits of treatment with TEGSEDI™ (inotersen) and results show continued efficacy with long-term exposure in the NEURO-TTR open-label extension study BOSTON, Nov. 29, 2018 (GLOBE NEWSWIRE [...]
ISS Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics
29/11/2018
Leading proxy advisory firm recognizes the strategic and financial merits of the merger BOSTON, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on [...]
Antares Pharma Announces the Commercial Availability of XYOSTED™ (Testosterone Enanthate) Injection — A New Treatment for Adult Men Diagnosed With Testosterone Deficiency
29/11/2018
XYOSTED™ - A Novel Subcutaneous Testosterone Auto Injector Product Approved For Once-Weekly At-Home Therapy EWING, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the [...]
FDA Approves Firdapse® (amifampridine) for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)
29/11/2018
- First evidenced-based medicine approved to treat LEMS - Catalyst Pathways™ designed to facilitate access to Firdapse® and provide dedicated patient support - Launch early in the first quarter of 2019 - Catalyst to [...]
US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the US
29/11/2018
Invivoscribe also Receives National Reimbursement for CDx Assay in Japan SAN DIEGO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Invivoscribe is pleased to announce FDA approval of both the LeukoStrat CDx FLT3 Mutation Assay and [...]
Virginia Spine Institute Expands World-Class Surgical Team With Hiring of Spine Surgeon Ehsan Jazini, MD
29/11/2018
Spine Surgeon Ehsan Jazini, MD, formerly of MedStar Health, joins Virginia Spine Institute to support growth of national spinal practice RESTON, Va., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Virginia Spine Institute welcomes [...]

Pages